Is a complete THC research report available?

No complete published report is available for Tenet Healthcare Corporation (THC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Tenet Healthcare Corporation (THC)

NYSE: THC · USD

$268

+5.53 (+2.1%)· Recorded snapshot

Market cap	21.5B
Revenue (ttm)	21.8B
Net income (ttm)	2.2B
EPS (ttm)	$25.7
Shares out	80.5M
P/E (trailing)	10.4x
P/E (forward)	12.8x
Volume	883,814
Beta	1.20

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0000070318
Company name	Tenet Healthcare Corporation
Country	United States
Country code	US
CUSIP number	88033G407
Earnings date	2026-10-29
Earnings time	bmo
Employees	99,000
Employees change	1,000
Employees growth	1.02%
Enterprise value	$32.6B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1967
Industry	Medical Care Facilities
Is primary listing	Yes
Is SPAC	No
ISIN number	US88033G4073
Last 10-K release date	2026-02-17
Last earnings date	2026-07-23
Last refreshed	2026-10-28
Last stock split date	2012-10-11
Last stock split type	Reverse
Market cap	$21.5B
Market cap category	Large-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$267.59
Price currency	USD
Sector	Healthcare
SIC code	8062
Stock price date	2026-10-28
Symbol	THC
U.S. state	Texas
Website	https://www.tenethealth.com

Metric

Value

Amount currency

USD

CIK code

0000070318

Company name

Tenet Healthcare Corporation

Country

United States

Country code

CUSIP number

88033G407

Earnings date

2026-10-29

Earnings time

bmo

Employees

99,000

Employees change

1,000

Employees growth

1.02%

Enterprise value

$32.6B

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1967

Industry

Medical Care Facilities

Is primary listing

Yes

Is SPAC

ISIN number

US88033G4073

Last 10-K release date

2026-02-17

Last earnings date

2026-07-23

Last refreshed

2026-10-28

Last stock split date

2012-10-11

Last stock split type

Reverse

Market cap

$21.5B

Market cap category

Large-Cap

Next earnings date

2026-10-29

Options

Yes

Price

$267.59

Price currency

USD

Sector

Healthcare

SIC code

8062

Stock price date

2026-10-28

Symbol

THC

U.S. state

Texas

Website

https://www.tenethealth.com

Metric	Value
Adjusted P/E ratio	13.84x
Average P/E ratio (3Y)	8.89x
Average P/E ratio (5Y)	9.66x
Earnings yield	9.62%
EV/Earnings	14.65x
EV/EBIT	8.31x
EV/EBITDA	6.78x
EV/FCF	10.86x
EV/Sales	1.51x
FCF / EV yield	9.21%
FCF yield	13.89%
Forward EV/Sales	1.47x
Forward P/E	12.83x
Forward P/S	0.97x
Graham number	183.08858
Graham upside	-32.25%
Industry forward P/E	14.95x
Industry P/E	18.37x
Lynch fair value	$643.75
Lynch upside	138.21%
P/(FCF - SBC) ratio	7.53x
P/(OCF - SBC) ratio	5.6x
P/B ratio	4.53x
P/E ratio	10.39x
P/FCF ratio	7.2x
P/OCF ratio	5.42x
P/S ratio	1x
PEG ratio	1x
Price/EBITDA ratio	4.49x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

13.84x

Average P/E ratio (3Y)

8.89x

Average P/E ratio (5Y)

9.66x

Earnings yield

9.62%

EV/Earnings

14.65x

EV/EBIT

8.31x

EV/EBITDA

6.78x

EV/FCF

10.86x

EV/Sales

1.51x

FCF / EV yield

9.21%

FCF yield

13.89%

Forward EV/Sales

1.47x

Forward P/E

12.83x

Forward P/S

0.97x

Graham number

183.08858

Graham upside

-32.25%

Industry forward P/E

14.95x

Industry P/E

18.37x

Lynch fair value

$643.75

Lynch upside

138.21%

P/(FCF - SBC) ratio

7.53x

P/(OCF - SBC) ratio

5.6x

P/B ratio

4.53x

P/E ratio

10.39x

P/FCF ratio

7.2x

P/OCF ratio

5.42x

P/S ratio

PEG ratio

Price/EBITDA ratio

4.49x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	18.11%
EBITDA margin	22.21%
Effective tax rate	17.88%
FCF margin	13.86%
Gross margin	41.66%
Operating margin	18.11%
Pretax margin	17.72%
Profit margin	10.27%
Profit per employee	$22,636
Profitable quarters	23
Profitable years	6
Revenue per employee	$220,323
ROA	8.32%
ROA (5Y)	6.58%
ROCE	15.74%
ROE	37.34%
ROE (5Y)	34.94%
ROIC	16.7%
ROIC (5Y)	12.01%
SBC / revenue	0.61%
Tax / revenue	3.17%

Metric

Value

EBIT margin

18.11%

EBITDA margin

22.21%

Effective tax rate

17.88%

FCF margin

13.86%

Gross margin

41.66%

Operating margin

18.11%

Pretax margin

17.72%

Profit margin

10.27%

Profit per employee

$22,636

Profitable quarters

Profitable years

Revenue per employee

$220,323

ROA

8.32%

ROA (5Y)

6.58%

ROCE

15.74%

ROE

37.34%

ROE (5Y)

34.94%

ROIC

16.7%

ROIC (5Y)

12.01%

SBC / revenue

0.61%

Tax / revenue

3.17%

Metric	Value
EPS growth	64.5%
EPS growth (Q)	213.38%
EPS growth (QoQ)	22.85%
EPS growth 3Y	77.12%
EPS growth 5Y	44.92%
EPS growth quarters	3
EPS growth years	0
FCF growth	94.66%
FCF growth (Q)	-43.88%
FCF growth (QoQ)	-71.46%
FCF growth 3Y	46.52%
FCF growth 5Y	17.97%
Gross profit growth	7.61%
Gross profit growth (Q)	10.75%
Gross profit growth 3Y	7.34%
Gross profit growth 5Y	5.13%
Net income growth	51.01%
Net income growth (Q)	186.81%
Net income growth (QoQ)	17.66%
Net income growth 3Y	64.99%
Net income growth 5Y	38.86%
Net income growth quarters	3
Net income growth years	0
OCF growth	62.88%
OCF growth (Q)	-37.5%
OCF growth (QoQ)	-64.35%
OCF growth 10Y	12.33%
OCF growth 3Y	31.07%
OCF growth 5Y	17.17%
Operating income growth	12.34%
Operating income growth (Q)	20.24%
Operating income growth 3Y	14.6%
Operating income growth 5Y	11.58%
Revenue growth	5.41%
Revenue growth (Q)	6.77%
Revenue growth (QoQ)	4.84%
Revenue growth 10Y	1.06%
Revenue growth 3Y	3.12%
Revenue growth 5Y	2.58%
Revenue growth quarters	5
Revenue growth years	3

Metric

Value

EPS growth

64.5%

EPS growth (Q)

213.38%

EPS growth (QoQ)

22.85%

EPS growth 3Y

77.12%

EPS growth 5Y

44.92%

EPS growth quarters

EPS growth years

FCF growth

94.66%

FCF growth (Q)

-43.88%

FCF growth (QoQ)

-71.46%

FCF growth 3Y

46.52%

FCF growth 5Y

17.97%

Gross profit growth

7.61%

Gross profit growth (Q)

10.75%

Gross profit growth 3Y

7.34%

Gross profit growth 5Y

5.13%

Net income growth

51.01%

Net income growth (Q)

186.81%

Net income growth (QoQ)

17.66%

Net income growth 3Y

64.99%

Net income growth 5Y

38.86%

Net income growth quarters

Net income growth years

OCF growth

62.88%

OCF growth (Q)

-37.5%

OCF growth (QoQ)

-64.35%

OCF growth 10Y

12.33%

OCF growth 3Y

31.07%

OCF growth 5Y

17.17%

Operating income growth

12.34%

Operating income growth (Q)

20.24%

Operating income growth 3Y

14.6%

Operating income growth 5Y

11.58%

Revenue growth

5.41%

Revenue growth (Q)

6.77%

Revenue growth (QoQ)

4.84%

Revenue growth 10Y

1.06%

Revenue growth 3Y

3.12%

Revenue growth 5Y

2.58%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-992M
Depreciation and amortization	$893M
EBIT	$4B
EBITDA	$4.8B
EPS	$25.75
FCF per share	$37.54
Financing cash flow	$-3.2B
Free cash flow	$3B
Free cash flow minus SBC	$2.9B
Gross profit	$9.1B
Income taxes	$691M
Investing cash flow	$-1.3B
Net borrowing	$-80M
Net cash flow	$-455M
Net income	$2.2B
Operating cash flow minus SBC	$3.9B
Operating income	$4B
Revenue	$21.8B
Stock-based compensation	$132M

Metric

Value

Capital expenditures

$-992M

Depreciation and amortization

$893M

EBIT

$4B

EBITDA

$4.8B

EPS

$25.75

FCF per share

$37.54

Financing cash flow

$-3.2B

Free cash flow

$3B

Free cash flow minus SBC

$2.9B

Gross profit

$9.1B

Income taxes

$691M

Investing cash flow

$-1.3B

Net borrowing

$-80M

Net cash flow

$-455M

Net income

$2.2B

Operating cash flow minus SBC

$3.9B

Operating income

$4B

Revenue

$21.8B

Stock-based compensation

$132M

Metric	Value
Altman Z-Score	1.96
Book value per share	$57.86
Debt / EBITDA	2.52
Debt / equity	1.52
Debt / FCF	4.38
Goodwill	$11.4B
Interest coverage	4.82
Long-term assets	$22.8B
Long-term liabilities	$16.4B
Net cash (debt)	$-11.1B
Net cash / market cap	-50.91%
Net debt / EBITDA	2.29
Net debt / equity	1.27
Net debt / FCF	3.66
Piotroski F-Score	7
Property, plant and equipment	$6.3B
Shareholders' equity	$8.7B
Tangible book value	$-8.1B
Tangible book value per share	$-100.12
Total assets	$30.7B
Total cash	$2.2B
Total debt	$13.2B
Total liabilities	$22B
WACC	8.66%

Metric

Value

Altman Z-Score

1.96

Book value per share

$57.86

Debt / EBITDA

2.52

Debt / equity

1.52

Debt / FCF

4.38

Goodwill

$11.4B

Interest coverage

4.82

Long-term assets

$22.8B

Long-term liabilities

$16.4B

Net cash (debt)

$-11.1B

Net cash / market cap

-50.91%

Net debt / EBITDA

2.29

Net debt / equity

1.27

Net debt / FCF

3.66

Piotroski F-Score

Property, plant and equipment

$6.3B

Shareholders' equity

$8.7B

Tangible book value

$-8.1B

Tangible book value per share

$-100.12

Total assets

$30.7B

Total cash

$2.2B

Total debt

$13.2B

Total liabilities

$22B

WACC

8.66%

Metric	Value
Asset turnover	0.73
Current assets	$7.8B
Current liabilities	$5.6B
Current ratio	1.41
Inventory turnover	37.65
Net working capital	$250M
Quick ratio	1.14
Working capital	$2.3B
Working capital turnover	8.25

Metric

Value

Asset turnover

0.73

Current assets

$7.8B

Current liabilities

$5.6B

Current ratio

1.41

Inventory turnover

37.65

Net working capital

$250M

Quick ratio

1.14

Working capital

$2.3B

Working capital turnover

8.25

Metric	Value
Buyback yield / dilution	8.21%
Dividend growth (10Y)	-30.02%
Dividend growth (3Y)	-72.48%
Dividend growth (5Y)	-53.89%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.03
Shareholder yield	8.21%

Metric

Value

Buyback yield / dilution

8.21%

Dividend growth (10Y)

-30.02%

Dividend growth (3Y)

-72.48%

Dividend growth (5Y)

-53.89%

Dividend per share

$0.00

Dividend yield

Last dividend

$0.03

Shareholder yield

8.21%

Metric	Value
10Y price change	1,185.98%
10Y return CAGR	29.1%
10Y total return	1,185.98%
150-day SMA	$221.48
15Y price change	1,196.64%
15Y return CAGR	18.63%
15Y total return	1,196.64%
1D price change	2.11%
1M price change	2.45%
1M total return	2.45%
1W price change	-2.3%
1W total return	-2.3%
1Y price change	23.08%
1Y return CAGR	23.1%
1Y total return	23.08%
20-day SMA	$265.42
200-day SMA	$219.45
20Y price change	701.42%
20Y return CAGR	10.97%
20Y total return	701.42%
3M price change	9.33%
3M total return	9.33%
3Y price change	400.89%
3Y return CAGR	71.08%
3Y total return	400.89%
50-day SMA	$264.77
50-day SMA vs 200-day SMA	50over200
52-week high	$283.05
52-week high date	2026-08-24
52-week low	$157.58
52-week low date	2026-06-08
5Y price change	279.23%
5Y return CAGR	30.56%
5Y total return	279.23%
6M price change	43.41%
6M total return	43.41%
All-time high	$283.05
All-time high date	2026-08-24
All-time low	$0.42
All-time low date	1974-09-16
Average true range (ATR)	$8.27
Average volume	586.9K
Beta (1Y)	0.71
Beta (2Y)	0.83
Beta (5Y)	1.2
Change from 52-week high	-5.46%
Change from 52-week low	69.81%
Change from all-time high	-6%
Change from all-time low	63,114.54%
Change from open	1.77%
Day's gap	0.34%
Dollar volume	$236.5M
High price	$271.14
Low price	$262.93
Monthly RSI	66.92
Open price	$262.93
Position in 52-week range	56.76%
Premarket change	-0.73%
Premarket close	$262.05
Premarket price	$260.15
Previous close	$262.05
Price vs 150-day SMA	20.13%
Price vs 20-day SMA	0.25%
Price vs 200-day SMA	21.25%
Price vs 50-day SMA	0.49%
Relative volume	1.51
RSI	51.3
Sharpe ratio	0.6
Sharpe ratio (3Y)	1.39
Sharpe ratio (5Y)	0.76
Sortino ratio	1.24
Sortino ratio (3Y)	2.48
Sortino ratio (5Y)	1.24
Volume	883.8K
Weekly RSI	63.63
YTD price change	33.89%
YTD total return	33.89%

Metric

Value

10Y price change

1,185.98%

10Y return CAGR

29.1%

10Y total return

1,185.98%

150-day SMA

$221.48

15Y price change

1,196.64%

15Y return CAGR

18.63%

15Y total return

1,196.64%

1D price change

2.11%

1M price change

2.45%

1M total return

2.45%

1W price change

-2.3%

1W total return

-2.3%

1Y price change

23.08%

1Y return CAGR

23.1%

1Y total return

23.08%

20-day SMA

$265.42

200-day SMA

$219.45

20Y price change

701.42%

20Y return CAGR

10.97%

20Y total return

701.42%

3M price change

9.33%

3M total return

9.33%

3Y price change

400.89%

3Y return CAGR

71.08%

3Y total return

400.89%

50-day SMA

$264.77

50-day SMA vs 200-day SMA

50over200

52-week high

$283.05

52-week high date

2026-08-24

52-week low

$157.58

52-week low date

2026-06-08

5Y price change

279.23%

5Y return CAGR

30.56%

5Y total return

279.23%

6M price change

43.41%

6M total return

43.41%

All-time high

$283.05

All-time high date

2026-08-24

All-time low

$0.42

All-time low date

1974-09-16

Average true range (ATR)

$8.27

Average volume

586.9K

Beta (1Y)

0.71

Beta (2Y)

0.83

Beta (5Y)

1.2

Change from 52-week high

-5.46%

Change from 52-week low

69.81%

Change from all-time high

-6%

Change from all-time low

63,114.54%

Change from open

1.77%

Day's gap

0.34%

Dollar volume

$236.5M

High price

$271.14

Low price

$262.93

Monthly RSI

66.92

Open price

$262.93

Position in 52-week range

56.76%

Premarket change

-0.73%

Premarket close

$262.05

Premarket price

$260.15

Previous close

$262.05

Price vs 150-day SMA

20.13%

Price vs 20-day SMA

0.25%

Price vs 200-day SMA

21.25%

Price vs 50-day SMA

0.49%

Relative volume

1.51

RSI

51.3

Sharpe ratio

0.6

Sharpe ratio (3Y)

1.39

Sharpe ratio (5Y)

0.76

Sortino ratio

1.24

Sortino ratio (3Y)

2.48

Sortino ratio (5Y)

1.24

Volume

883.8K

Weekly RSI

63.63

YTD price change

33.89%

YTD total return

33.89%

Metric	Value
Float	79.7M
Float percentage	98.96%
Shares change (QoQ)	-4.15%
Shares change (YoY)	-8.21%
Shares held by insiders	0.89%
Shares held by institutions	99.46%
Shares outstanding	80.5M
Short % of float	2.29%
Short % of shares	2.27%
Short ratio	2.3 days

Metric

Value

Float

79.7M

Float percentage

98.96%

Shares change (QoQ)

-4.15%

Shares change (YoY)

-8.21%

Shares held by insiders

0.89%

Shares held by institutions

99.46%

Shares outstanding

80.5M

Short % of float

2.29%

Short % of shares

2.27%

Short ratio

2.3 days

Tenet Healthcare Corporation (THC)

Price

Financial snapshot

Fair-value bridge

Latest news · THC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All THC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on THC

Frequently asked questions